16 March 2023
Leucid Bio, announced an agreement
2 March 2023
This Briefing from Advanced Therapies
7 February 2023
The Janssen Pharmaceutical Companies of
3 February 2023
Jeff Buck, Vice President, Adherence
1 February 2023
NICE has announced the approval
20 January 2023
Global leader in custom development
19 January 2023
UK-based provider of next-generation bioreactors
21 December 2022
In this interview, Brandon McNaughton,
